Comparing Bimekizumab vs Secukinumab
| Bimekizumab | Secukinumab |
|
|---|
| Bimekizumab | Secukinumab |
|
|---|---|---|
|
Prescription only
Prescribed for Hidradenitis Suppurativa, Psoriatic Arthritis, Ankylosing Spondylitis, Non-Radiographic Axial Spondyloarthritis, Plaque Psoriasis. Bimekizumab may also be used for purposes not listed... View more |
Prescription only
Prescribed for Hidradenitis Suppurativa, Ankylosing Spondylitis, Enthesitis-Related Arthritis, Non-Radiographic Axial Spondyloarthritis, Plaque Psoriasis, Psoriasis, Psoriatic Arthritis. Secukinumab... View more |
Related suggestions |
| More about Bimekizumab | More about Secukinumab | |
| Ratings & Reviews | ||
|
Bimekizumab has an average rating of 8.2 out of 10 from a total of 22 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 0% reported a negative effect. |
Secukinumab has an average rating of 6.4 out of 10 from a total of 267 ratings on Drugs.com. 53% of reviewers reported a positive effect, while 30% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
|
View all Bimekizumab side effects |
View all Secukinumab side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Bimzelx | Cosentyx | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
552 hours |
744 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 317 drugs are known to interact with Bimekizumab:
|
A total of 253 drugs are known to interact with Secukinumab:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
| First Approval Date | ||
|
October 17, 2023 |
January 21, 2015 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.